CBI’s 4th Annual Specialty Pharmacy Network Design Summit

CBI’s 4th Annual Specialty Pharmacy Network Design Summit June 14-15, 2018 | Washington, DC Prescription dispensing revenues from specialty drugs at retail, mail, long-term care, and specialty pharmacies reached $138 billion in 2017. That amount accounts for one-third of the 2017 pharmacy industry’s $413 billion in total dispensing revenues. By 2022, prescription dispensing revenues from specialty drugs will account for $271 billion, almost half of the pharmacy industry’s projected $576 billion in total dispensing revenues. (See The 2018 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, exhibit 70.) At CBI’s 4th Annual Specialty Pharmacy Network Design Summit, gain the … Continue reading CBI’s 4th Annual Specialty Pharmacy Network Design Summit

Who Best Managed the Drug Spending Slowdown in 2017: CVS Health, Express Scripts, MedImpact, or Prime Therapeutics?

It’s time for Drug Channels’ annual analysis of drug spending. For 2017, we again turn to the annual trend reports from four large pharmacy benefit managers (PBMs)—CVS Health, Express Scripts, MedImpact, and Prime Therapeutics. (See their report links below.) Below, I compare who’s better and who’s best among the PBMs and share additional observations about the 2017 trends. We offer four key conclusions: Drug spending grew by only 1.5% in 2017, continuing a multiyear decline in the growth rate. Total drug spending declined at more than 40% of plan sponsors. Spending on traditional drugs dropped by mid-single digits. For specialty … Continue reading Who Best Managed the Drug Spending Slowdown in 2017: CVS Health, Express Scripts, MedImpact, or Prime Therapeutics?

Informal, Formal – End 4 E-Learning

Some folks generate a level of enthusiasm when talking about days gone by.  And show it, via retro gaming, whereas folks buying NES and SNES 32 bit.  Sega is launching their days gone by console with Sonic Hedgehog.  Folks attend Renaissance fairs. Go to an autograph store and folks buy autographs of their “favorite players” back in the day. Perhaps you wish to travel back to another time, an easier time.  I would love to experience Victorian England, but only if I had money, because if I was poor, it was downright awful. Just the other day, in my adopted … Continue reading Informal, Formal – End 4 E-Learning

CBI’s Reimbursement and Access 2018

Reimbursement and Access 2018 August 15-16, 2018 | Philadelphia, PA www.cbinet.com/reimbursement For all companies within the life sciences arena, staying on the pulse of emerging trends, ensuring favorable reimbursement and justifying product prices are core pillars of overall product success. Whether your organization is pre-commercial or managing multiple products, CBI’s highly-acclaimed Reimbursement and Access arms attendees with invaluable learning, practical strategies and tangible takeaways on the most impactful ways to reduce barriers to access. Join CBI in Philadelphia this August 15-16 at Reimbursement and Access 2018 for unparalleled insights and practical expertise. Register today! Drug Channels readers will save $500 … Continue reading CBI’s Reimbursement and Access 2018

The Trump Drug Pricing Plan: Short Term Reprieve, Long Term Disruption

Last Friday, the U.S. Department of Health & Human Services (HHS) released American Patients First, a report billed as “The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” This administration’s blueprint offers a thoughtful diagnosis of U.S. drug pricing along with the unintended consequences and warped incentives of our drug channel system. The report also proposes a very long list of more than 50 regulatory and legislative fixes. It therefore doesn’t translate to quick action or simple sound bites. Many people are discounting the plan as no big deal and therefore underestimating how radically the system could … Continue reading The Trump Drug Pricing Plan: Short Term Reprieve, Long Term Disruption

Improving Regulatory Resource Management through Systematic Measurement

As submissions complexity intensifies, life sciences firms are finding that the key to better resource management is better measurement, writes Adrian Leibert. Regulatory demands in the life sciences world are not only increasing in volume and complexity; submissions workloads are also Powered by WPeMatico Continue reading Improving Regulatory Resource Management through Systematic Measurement